Pathogenesis and diagnosis of bile acid diarrhea

doi:10.3877/cma.j.issn.2095-3224.2022.05.012

Abstract

Abstract:

Bile acid diarrhea (BAD) is a common cause of chronic diarrhea, with a high incidence rate but missed diagnosis. In recent years, the attention of European and American countries has gradually increased. However, little is known about it in China. This article introduces the mechanism of BAD and the common diagnostic methods of BAD in the world, and discusses the advantages and disadvantages of various methods.

Key words: Colon, Bile acids and salts, Diarrhea, Clinical application

Ning Mao, Yong Zhu. Pathogenesis and diagnosis of bile acid diarrhea[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2022, 11(05): 425-428.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhjzcjbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3224.2022.05.012

https://zhjzcjbdzzz.cma-cmc.com.cn/EN/Y2022/V11/I05/425

Figures/Tables 1

References 40

[1]	Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition[J]. Gut, 2018, 67(8): 1380-1399.
[2]	Wong BS, Camilleri M, Carlson P, et al. Increased bile acid biosynthesis is associated with irritable bowel syndrome with diarrhea[J]. Clin Gastroenterol Hepatol, 2012, 10(9): 1009-1015.e3.
[3]	Valentin N, Camilleri M, Altayar O, et al. Biomarkers for bile acid diarrhoea in functional bowel disorder with diarrhoea: a systematic review and meta-analysis[Z]. Gut, 2016, 65(12): 1951-1959.
[4]	MartÍnez-augustin O, Medina FSD. Intestinal bile acid physiology and pathophysiology[J]. World Journal of Gastroenterology, 2008, 14(37): 5630.
[5]	Ticho AL, Malhotra P, Dudeja PK, et al. Intestinal absorption of bile acids in health and disease[J]. Compr Physiol, 2019, 10(1): 21-56.
[6]	Magnus Y, Bousaba J, Sannaa W, et al. Bile acid diarrhea is associated with increased intestinal permeability compared with irritable bowel syndrome-diarrhea[J]. Gastroenterology, 2022, 162(4): 1343-1345.
[7]	Camilleri M. Bile Acid diarrhea: prevalence, pathogenesis, and therapy[J]. Gut Liver, 2015, 9(3): 332-339.
[8]	Sadowski DC, Camilleri M, Chey WD, et al. Canadian association of gastroenterology clinical practice guideline on the management of bile acid diarrhea[J]. Journal of the Canadian Association of Gastroenterology, 2020, 3(1): e10-e27.
[9]	Merrick MV, Eastwood MA, Anderson JR, et al. Enterohepatic circulation in man of a gamma-emitting bile-acid conjugate, 23-selena-25-homotaurocholic acid (SeHCAT)[J]. J Nucl Med, 1982, 23(2): 126-130.
[10]	Black CJ, Ford AC. Biochemical tests for bile acid diarrhea: real-world studies required[J]. Am J Gastroenterol, 2021, 16(4): 833-834.
[11]	Brydon WG, Nyhlin H, Eastwood MA, et al. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea[J]. Eur J Gastroenterol Hepatol, 1996, 8(2): 117-123.
[12]	Camilleri M, Nadeau A, Tremaine W J, et al. Measurement of serum 7α-hydroxy-4-cholesten-3-one (or 7αC4), a surrogate test for bile acid malabsorption in health, ileal disease and irritable bowel syndrome using liquid chromatography-tandem mass spectrometry[J]. Neurogastroenterology & Motility, 2009, 21(7): 734-743.
[13]	GÄlman C, Angelin B, Rudling M. Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis[J]. Gastroenterology, 2005, 129(5): 1445-1453.
[14]	Walters J. Making the diagnosis of bile acid diarrhea[J]. Am J Gastroenterol, 2020, 115(12): 1974-1975.
[15]	Mottacki N, SimrÉn M, Bajor A, et al. Review article: bile acid diarrhoea-pathogenesis, diagnosis and management[J]. Alimentary pharmacology & therapeutics, 2016, 43(8): 884-898.
[16]	Vijayvargiya P, Camilleri M, Shin A, et al. Methods for diagnosis of bile acid malabsorption in clinical practice[J]. Clinical Gastroenterology and Hepatology, 2013, 11(10): 1232-1239.
[17]	Walters JR. Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy[J]. Nat Rev Gastroenterol Hepatol, 2014, 11(7): 426-434.
[18]	Chang C, Jiang J, Sun R, et al. Downregulation of serum and distal ileum fibroblast growth factor19 in bile acid diarrhoea patients[J]. Dig Dis Sci, 2022, 67(3): 872-879.
[19]	Pattni SS, Brydon WG, Dew T, et al. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention[J]. Aliment Pharmacol Ther, 2013, 38(8): 967-976.
[20]	Pattni SS, Brydon GW, Dew T, et al. Fibroblast growth factor 19 and 7α-hydroxy-4-cholesten-3-one in the diagnosis of patients with possible bile acid diarrhea[J]. Clinical and Translational Gastroenterology, 2012, 3(7): e18.
[21]	Borup C, Syversen C, Bouchelouche P, et al. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19[J]. Eur J Gastroenterol Hepatol, 2015, 27(12): 1399-1402.
[22]	Borup C, Wildt S, Rumessen JJ, et al. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea[J]. Aliment Pharmacol Ther, 2017, 45(11): 1433-1442.
[23]	Amplatz B, ZÖhrer E, Haas C, et al. Bile acid preparation and comprehensive analysis by high performance liquid chromatography-high-resolution mass spectrometry[J]. Clin Chim Acta, 2017, 464: 85-92.
[24]	Vijayvargiya P, Camilleri M, Chedid V, et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea[J]. Clinical Gastroenterology and Hepatology, 2019, 17(5): 922-929.
[25]	Vijayvargiya P, Camilleri M, Taylor A, et al. Combined fasting serum c4 and primary bile acids from a single stool sample to diagnose bile acid diarrhea[J]. Gastroenterology, 2020, 159(5): 1952-1954.
[26]	Vijayvargiya P, Gonzalez Izundegui D, Calderon G, et al. Fecal bile acid testing in assessing patients with chronic unexplained diarrhea: implications for healthcare utilization[J]. American Journal of Gastroenterology, 2020, 115(7): 1094-1102.
[27]	Kumar A, Al-hassi HO, Jain M, et al. A single faecal bile acid stool test demonstrates potential efficacy in replacing SeHCAT testing for bile acid diarrhoea in selected patients[J]. Scientific Reports, 2022, 12(1): 8313.
[28]	Vijayvargiya P, Camilleri M. Current practice in the diagnosis of bile acid diarrhea[J]. astroenterology 2019, 156(5): 1233-1238.
[29]	Covington JA, Westenbrink EW, Ouaret N, et al. Application of a novel tool for diagnosing bile acid diarrhoea[J]. Sensors (Basel), 2013, 13(9): 11899-11912.
[30]	Berti G, Rettura F, Lambiase C, et al. Empirical trial or diagnostic tests for bile acid diarrhea? That is the question![J]. Journal of Digestive Diseases, 2021, 22(9): 557-558.
[31]	Ferguson J, Walker K, Thomson AB. Limitations in the use of 14C-glycocholate breath and stool bile acid determinations in patients with chronic diarrhea[J]. 1986, 8(3 Pt 1): 258-262.
[32]	Orekoya O, Mclaughlin J, Leitao E, et al. Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy[J]. Clin Med (Lond), 2015, 15(3): 252-257.
[33]	Watson L, Lalji A, Bodla S, et al. Management of bile acid malabsorption using low-fat dietary interventions: a useful strategy applicable to some patients with diarrhoea-predominant irritable bowel syndrome?[J]. Clinical Medicine (London, England), 2015, 15(6): 536-540.
[34]	Koga T, Nishida T, Miwa H, et al. Effects of dietary butter fat on fecal bile acid excretion in patients with Crohn's disease on elemental diet[J]. Dig Dis Sci, 1984, 29(11): 994-999.
[35]	Walters JRF, Johnston IM, Nolan JD, et al. The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid[J]. Alimentary Pharmacology & Therapeutics, 2015, 41(1): 54-64.
[36]	Mroz MS, Keating N, Ward JB, et al. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo[J]. Gut, 2014, 63(5): 808-817.
[37]	Camilleri M, Vijayvargiya P. The role of bile acids in chronic diarrhea[J]. American Journal of Gastroenterology, 2020, 115(10): 1596-1603.
[38]	Lin S, Sanders DS, Gleeson JT, et al. Long-term outcomes in patients diagnosed with bile-acid diarrhoea[J]. Eur J Gastroenterol Hepatol, 2016, 28(2): 240-245.
[39]	Farrugia A, Arasaradnam R. Bile acid diarrhoea: pathophysiology, diagnosis and management[J]. Frontline Gastroenterology, 2021, 12(6): 500-507.
[40]	Wilcox C, Turner J, Green J. Systematic review: the management of chronic diarrhoea due to bile acid malabsorption[J]. Alimentary Pharmacology & Therapeutics, 2014, 39(9): 923-939.

肝脏胆汁酸生产过剩	胆汁酸吸收不良
先天性	克罗恩病
胆囊切除术后	右半结肠切除术后
肠易激综合征—腹泻型	肠病（例如HIV相关型肠病）
胰腺功能不全	盆腔放疗
	迷走神经切断术
	显微镜下结肠炎
	肠道菌群紊乱

肝脏胆汁酸生产过剩	胆汁酸吸收不良
先天性	克罗恩病
胆囊切除术后	右半结肠切除术后
肠易激综合征—腹泻型	肠病（例如HIV相关型肠病）
胰腺功能不全	盆腔放疗
	迷走神经切断术
	显微镜下结肠炎
	肠道菌群紊乱

Please choose a citation manager

Content to export